Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine Botto

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Frontiers in Genome Editing|November 15, 2021
Progress in Gene Editing Tools and Their Potential for Correcting Mutations Underlying Hearing and Vision LossCatherine Botto, Deniz Dalkara, Aziz El-Amraoui
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
Basic Science and PathogenesisNoelle Callizot, Laura Rouvière, Catherine Botto, et al.
Progress in Retinal and Eye Research|May 31, 2021
Early and late stage gene therapy interventions for inherited retinal degenerationsCatherine Botto, Marco Rucli, Müge Defne Tekinsoy, et al.
Molecular Therapy. Nucleic Acids|November 4, 2024
Direct delivery of Cas9 or base editor protein and guide RNA complex enables genome editing in the retinaJuliette Pulman, Catherine Botto, Hugo Malki, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Frontiers in Genome Editing|November 15, 2021
Progress in Gene Editing Tools and Their Potential for Correcting Mutations Underlying Hearing and Vision LossCatherine Botto, Deniz Dalkara, Aziz El-Amraoui
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
Basic Science and PathogenesisNoelle Callizot, Laura Rouvière, Catherine Botto, et al.
Progress in Retinal and Eye Research|May 31, 2021
Early and late stage gene therapy interventions for inherited retinal degenerationsCatherine Botto, Marco Rucli, Müge Defne Tekinsoy, et al.
Molecular Therapy. Nucleic Acids|November 4, 2024
Direct delivery of Cas9 or base editor protein and guide RNA complex enables genome editing in the retinaJuliette Pulman, Catherine Botto, Hugo Malki, et al.
Pageof 1